Literature DB >> 30191104

Role of Chemiluminescence examination as non-invasive diagnostic tool in early detection of Leukoplakia.

Nidhi Jain1, Anil Kumar Nagarajappa2,3, Meenakshi Bhasin4, Divya Pandya5, Kaushal Pati Tripathi6.   

Abstract

OBJECTIVES: To assess the efficacy of Chemiluminescent light (Vizilite plus) in enhancing visualization and its ability to highlight Leukoplakia lesion.
MATERIAL AND METHODS: This was a cross-sectional study done on 40 study subjects. Subjects were inducted into the study irrespective of age and sex based on the specific inclusion and exclusion criteria. The lesion parameters like the location of the lesion, the shape of lesion, the size, the extent, borders and the presence or absence of any adjacent satellite lesions were assessed under Incandescent light followed by Toluidine blue and Vizilite plus examinations. Histopathological examination results were considered as the gold standard and TBLU and CHEM outcomes were compared to them.
RESULTS: Vizilite plus examination method was most effective in assessing the size, borders and shape of the lesions followed by Toluidine blue and Incandescent light examinations. Toluidine blue and Vizilite plus examination methods demonstrated the sensitivity of 100% and specificity of 97.3%. They also demonstrated PPV of 100% and NPV of 75% with reliable accuracy of 97.5%.
CONCLUSION: Chemiluminescent light is a stepping stone and has the potential to revolutionize the diagnostic protocol for patients with potentially premalignant lesions. The device can be used as a general oral mucosal examination system and may in particular improve the visualization of potentially premalignant lesions.

Entities:  

Keywords:  Chemiluminescent; Dysplasia; Leukoplakia; OSCCs; Toluidine blue; Viziliteplus

Year:  2017        PMID: 30191104      PMCID: PMC6107910          DOI: 10.1016/j.jobcr.2017.04.004

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  11 in total

1.  Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses.

Authors:  K H Awan; P R Morgan; S Warnakulasuriya
Journal:  J Oral Pathol Med       Date:  2011-05-26       Impact factor: 4.253

2.  Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.

Authors:  S Ram; C H Siar
Journal:  Int J Oral Maxillofac Surg       Date:  2005-01-26       Impact factor: 2.789

3.  A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions.

Authors:  Camile S Farah; Michael J McCullough
Journal:  Oral Oncol       Date:  2006-12-13       Impact factor: 5.337

4.  Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.

Authors:  J B Epstein; S Silverman; J D Epstein; S A Lonky; M A Bride
Journal:  Oral Oncol       Date:  2007-11-08       Impact factor: 5.337

5.  The application of vizilite in oral cancer.

Authors:  Thirugnana Sambandham; K M K Masthan; M Sathish Kumar; Abhinav Jha
Journal:  J Clin Diagn Res       Date:  2013-01-01

Review 6.  Oral cancer: current and future diagnostic techniques.

Authors:  Crispian Scully; José V Bagan; Colin Hopper; Joel B Epstein
Journal:  Am J Dent       Date:  2008-08       Impact factor: 1.522

7.  Molecular predictors in the early diagnosis of oral cancer.

Authors:  S Rajkumari; J Sathiyajeeva; C Santhosh Kumar; P M Sunil; B Thayumanavan
Journal:  J Clin Diagn Res       Date:  2013-03-21

Review 8.  Leuloplakia - review of a potentially malignant disorder.

Authors:  Mohammed Abidullah; G Kiran; Kavitha Gaddikeri; Swetha Raghoji; Shilpa Ravishankar T
Journal:  J Clin Diagn Res       Date:  2014-08-20

9.  Oral Leukoplakia as It Relates to HPV Infection: A Review.

Authors:  L Feller; J Lemmer
Journal:  Int J Dent       Date:  2012-02-28

Review 10.  Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma--a systematic review.

Authors:  Esam Omar
Journal:  Head Face Med       Date:  2015-03-25       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.